drugset / Trial / NCT02624544

Proton Pump Inhibitors Use in Patients With Psoriasis

NCT02624544 ↗

Phase 4 Withdrawn EMS
RandomizedParallel-groupOpen-labelTreatment

Summary

Proton pump inhibitors act in blocking acid secretion and also have antioxidant and anti-inflammatory properties. For that mechanisms possibly PPIs may have an anti-inflammatory action with improvement in skin lesions in patients with psoriasis.

Timeline

Start
2016-01
Primary completion
2016-01
Completion
2016-12

Outcome

Outcome not reported

Stopped (Business): “Sponsor decision”

Drugs

EvaluationDrugModalityDoseRoute
Comparator Desonide Small molecule 0.1 % Topical
Subject Esomeprazole Small molecule 40 mg —

Indications